| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(20000120)89:1<32::AID-IJC6>3.0.CO;2-G |
| P698 | PubMed publication ID | 10719728 |
| P50 | author | Julie M. Cunningham | Q67440680 |
| P2093 | author name string | S S Sommer | |
| A Hartmann | |||
| L E Wold | |||
| H Blaszyk | |||
| J S Kovach | |||
| D Schaid | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer | Q27851503 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| Cancer. p53, guardian of the genome | Q29615610 | ||
| The relationship between prognostic and predictive factors in the management of breast cancer | Q33538455 | ||
| Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies | Q34400583 | ||
| Prognostic significance of TP53 alterations in breast carcinoma | Q35976693 | ||
| TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material | Q36135944 | ||
| Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value | Q37730372 | ||
| The molecular epidemiology of p53 gene mutations in human breast cancer | Q41331238 | ||
| William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer | Q43552305 | ||
| Predicting response to cancer chemotherapy: the role of p53. | Q45887109 | ||
| Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas | Q50802481 | ||
| Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States | Q52862568 | ||
| Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. | Q53350484 | ||
| p53 protein overexpression and chemosensitivity in breast cancer. | Q54172779 | ||
| Mutant p53 protein associated with chemosensitivity in breast cancer specimens. | Q54189041 | ||
| Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations | Q68170270 | ||
| Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis | Q71019316 | ||
| Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis | Q71019320 | ||
| The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry | Q71082995 | ||
| Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients | Q71169983 | ||
| p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective | Q71191754 | ||
| Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer | Q71198612 | ||
| Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy | Q71563602 | ||
| p53 status and the efficacy of cancer therapy in vivo | Q72839445 | ||
| Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer | Q74013133 | ||
| Prognosis and prediction of response in breast cancer: the current role of the main biological markers | Q77683176 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 32-38 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. | |
| P478 | volume | 89 |
| Q36442296 | A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells |
| Q52133539 | A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage. |
| Q40643483 | Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines |
| Q47887299 | DNA repair and breast carcinoma susceptibility in women |
| Q46131826 | Detection of ultrarare somatic mutation in the human TP53 gene by bidirectional pyrophosphorolysis-activated polymerization allele-specific amplification |
| Q35132901 | Glucose deprivation increases nuclear DNA repair protein Ku and resistance to radiation induced oxidative stress in human cancer cells |
| Q36936952 | Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study |
| Q73443300 | Mutation analysis of p53 in ovarian tumors by DHPLC |
| Q36308536 | P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection |
| Q24811790 | Perspectives on the chemical etiology of breast cancer |
| Q77397523 | Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients |
| Q24813658 | Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q37244111 | State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments |
| Q89727347 | TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines |
| Q35078761 | TP53 and breast cancer |
| Q41236981 | The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome. |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q24617837 | Zeranol down-regulates p53 expression in primary cultured human breast cancer epithelial cells through epigenetic modification |
| Q34580735 | p53 as a mutagen test in breast cancer |
Search more.